{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:35:35Z","timestamp":1790019335762,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":442,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"FWF\u2013Austrian Science Fund","doi-asserted-by":"crossref","award":["P21162"],"award-info":[{"award-number":["P21162"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.freeradbiomed.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,4,14]],"date-time":"2012-04-14T15:28:44Z","timestamp":1334417324000},"page":"2120-2127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome"],"prefix":"10.1016","volume":"52","author":[{"given":"Ai-Ching","family":"Boon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavisha","family":"Bakrania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/15353702-0322805-29","article-title":"Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies","volume":"228","author":"Novotny","year":"2003","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0065-2423(10)50003-9","article-title":"Serum bilirubin levels and cardiovascular disease risk: a Janus Bifrons?","volume":"50","author":"Franchini","year":"2010","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2423(06)43001-8","article-title":"The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases","volume":"43","author":"Vitek","year":"2007","journal-title":"Adv. Clin. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/FPC.0b013e328012d0da","article-title":"Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter","volume":"17","author":"Hsieh","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2007.11.022","article-title":"Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection","volume":"199","author":"Bulmer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1440-1746.2006.04564.x","article-title":"Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome","volume":"22","author":"Vitek","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib7","first-page":"387","article-title":"Decreased levels of advanced glycation end-products in patients with Gilbert syndrome","volume":"51","author":"Kalousova","year":"2005","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib8","first-page":"841","article-title":"Antioxidant activities of bile pigments","volume":"6","author":"Stocker","year":"2004","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tips.2007.03.006","article-title":"Restoring homeostasis: is heme oxygenase-1 ready for the clinic?","volume":"28","author":"Scott","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"Vitek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.75.3.443","article-title":"\u2018Like a shrivelled blood orange\u2019\u2014bilirubin, jaundice, and phototherapy","volume":"75","author":"McDonagh","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/000456329903600307","article-title":"Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler\u2013Najjar syndrome","volume":"36","author":"Ihara","year":"1999","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0891-5849(95)00032-S","article-title":"Hyperbilirubinemia results in reduced oxidative injury in neonatal Gunn-rats exposed to hyperoxia","volume":"19","author":"Dennery","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1651-2227.2010.02069.x","article-title":"Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity","volume":"100","author":"Kao","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.jp.7210887","article-title":"Does elevated peak bilirubin protect from retinopathy of prematurity in very low birthweight infants","volume":"23","author":"Milner","year":"2003","journal-title":"J. Perinatol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3928\/0191-3913-20020501-06","article-title":"No clinical correlation between bilirubin levels and severity of retinopathy of prematurity","volume":"39","author":"Hosono","year":"2002","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib17","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.2174\/138161209789058174","article-title":"Redox state, oxidative stress, and molecular mechanisms of protective and toxic effects of bilirubin on cells","volume":"15","author":"Tell","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib18","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/clinchem\/41.10.1421","article-title":"National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement","volume":"41","author":"Stein","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib19","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program, U.S. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary. Bethesda: National Institutes of Health; 2001.","DOI":"10.1001\/jama.285.19.2486"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib20","first-page":"77","article-title":"Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society","volume":"8","author":"European Atherosclerosis Society","year":"1987","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/cs0840407","article-title":"A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates","volume":"84","author":"Miller","year":"1993","journal-title":"Clin. Sci. (London)"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0955-2863(95)00177-8","article-title":"Determination of human plasma and leukocyte ascorbic acid by microtiter plate assay","volume":"7","author":"Wei","year":"1996","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.freeradbiomed.2009.01.007","article-title":"Quantification of protein modification by oxidants","volume":"46","author":"Hawkins","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","article-title":"Determination of carbonyl content in oxidatively modified proteins","volume":"186","author":"Levine","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","article-title":"A fluorometric method for determination of oxidized and reduced glutathione in tissues","volume":"74","author":"Hissin","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib28","series-title":"Robbins and Cotran pathologic basis of disease","author":"Kumar","year":"2010"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib29","first-page":"131","article-title":"Further evidence of altered redox status of hyperbilirubinaemic patients: role of bilirubin in Gilbert syndrome","volume":"47","author":"Hagym\u00e1si","year":"2003","journal-title":"Acta Biol. Szeged."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib30","doi-asserted-by":"crossref","first-page":"e29078","DOI":"10.1371\/journal.pone.0029078","article-title":"Functional induction of the cystine\u2013glutamate exchanger system XC-activity in SH-SY5Y cells by unconjugated bilirubin","volume":"6","author":"Giraudi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/aje\/kwp167","article-title":"Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality","volume":"170","author":"Pocobelli","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib32","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1582-4934.2010.01098.x","article-title":"Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress","volume":"15","author":"Muchova","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib33","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1139\/Y07-077","article-title":"Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection","volume":"85","author":"Muchova","year":"2007","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-5793(93)80353-V","article-title":"Bilirubin attenuates radical-mediated damage to serum albumin","volume":"331","author":"Neuzil","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/abbi.1998.0584","article-title":"Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma","volume":"352","author":"Minetti","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib36","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1016\/S0021-9258(20)64313-7","article-title":"Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide","volume":"266","author":"Radi","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(03)00420-4","article-title":"Interaction of bilirubin and biliverdin with reactive nitrogen species","volume":"543","author":"Kaur","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib38","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.bcp.2003.08.022","article-title":"Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide","volume":"66","author":"Mancuso","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.clinbiochem.2006.02.004","article-title":"Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease","volume":"39","author":"Serdar","year":"2006","journal-title":"Clin. Biochem."},{"issue":"Suppl.","key":"10.1016\/j.freeradbiomed.2012.03.002_bib40","first-page":"S99","article-title":"Human studies related to protein oxidation: protein carbonyl content as a marker of damage","volume":"33","author":"Chevion","year":"2000","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib41","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clinbiochem.2010.12.003","article-title":"Decreased small dense LDL levels in Gilbert's syndrome","volume":"44","author":"Tapan","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib42","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1440-1746.2008.05388.x","article-title":"Decreased oxidation susceptibility of plasma low density lipoproteins in patients with Gilbert's syndrome","volume":"23","author":"Yesilova","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib43","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1073\/pnas.84.22.8130","article-title":"Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile","volume":"84","author":"Stocker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib44","first-page":"360","article-title":"Relationship between unconjugated hyperbilirubinemia and lipoprotein spectrum","volume":"32","author":"Ocadlik","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.clinbiochem.2009.02.005","article-title":"Soluble CD40 ligand and soluble P-selectin levels in Gilbert's syndrome: a link to protection against atherosclerosis?","volume":"42","author":"Tapan","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1478-3231.2008.01821.x","article-title":"Bilirubin concentration and cardiovascular risk profile","volume":"29","author":"Lippi","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib47","first-page":"887","article-title":"Serum bilirubin and 10-year mortality risk in a Belgian population","volume":"12","author":"Temme","year":"2001","journal-title":"Cancer Causes Control"},{"issue":"Suppl.","key":"10.1016\/j.freeradbiomed.2012.03.002_bib48","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.3346\/jkms.2009.24.S1.S22","article-title":"The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy","volume":"24","author":"Chin","year":"2009","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib49","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1515\/cclm.2011.662","article-title":"Relationship between bilirubin and C-reactive protein","volume":"49","author":"Hwang","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib50","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.2011.124","article-title":"Serum bilirubin and risk of respiratory disease and death","volume":"305","author":"Horsfall","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib51","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.cca.2010.06.003","article-title":"Inverse relationship between fasting direct bilirubin and metabolic syndrome in Korean adults","volume":"411","author":"Hwang","year":"2010","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib52","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/ATVBAHA.110.211789","article-title":"The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus","volume":"31","author":"Dekker","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib53","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/hq0801.093592","article-title":"Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions","volume":"21","author":"Nakayama","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/01.ATV.0000124892.90999.cb","article-title":"Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper","volume":"24","author":"Stadler","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib55","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib56","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.mehy.2006.12.069","article-title":"\u201cIatrogenic Gilbert syndrome\u201d\u2014a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin","volume":"69","author":"McCarty","year":"2007","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.freeradbiomed.2012.03.002_bib57","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1476-5381.2011.01413.x","article-title":"Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration","volume":"164","author":"Bulmer","year":"2011","journal-title":"Br. J. Pharmacol."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584912001736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584912001736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:03:41Z","timestamp":1760202221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584912001736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0891584912001736"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.03.002","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}